Core Laboratories Q4 2024 Earnings Report

Core Laboratories EPS Results

• Actual EPS: $0.23
• Consensus EPS: $0.23
• Beat/Miss: Met Expectations
• One Year Ago EPS: N/A

Core Laboratories Revenue Results

• Actual Revenue: N/A
• Expected Revenue: $133.35 million
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Core Laboratories Announcement Details

• Quarter: Q4 2024
• Date: 1/29/2025
• Time: After Market Closes

Core Laboratories (NYSE:CLB) provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.